CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
News

Glox Therapeutics Awarded Grant to Accelerate Development of Precision Antibiotics

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 ...
Continue Reading →
News

Researchers in Japan devise method to produce steroid antibiotics

A group of steroid antibiotic compounds derived from fungi have shown promising antimicrobial activity. A group of researchers at the University of Tokyo, J...
Continue Reading →
News

Superbugs: First Independent Comparison of Pharma Companies' Efforts to Address Drug-resistant Infections

The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, finds that as well as dev...
Continue Reading →
News

Call for ‘renewed focus’ on deadly threat from antibiotic resistance

The spectre of a dwindling supply of effective antibiotics is considered one of the gravest threats to public health – one that could soon claim more lives than canc...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026